Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Studies in Health Technology and Informatics|December 11, 2003
Law and standards faced to market rules in health information securityF A Allaert, G Le Teuff, C Quantin
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2015
Hypertension and angiotensin system inhibitors: impact on outcome in sunitinib-treated patients for metastatic renal cell carcinomaH Izzedine, L Derosa, G Le Teuff, et al.
Methods of Information in Medicine|January 10, 2006
Improving model robustness with bootstrapping -- application to optimal discriminant analysis for ordinal responses (ODAO)G Le Teuff, C Quantin, A Venot, et al.
Neuroepidemiology|August 22, 2008
Clinical parameters to predict response to interferon in relapsing multiple sclerosisA Fromont, M Debouverie, G Le Teuff, et al.
Gynecologie, Obstetrique & Fertilite|July 1, 2008
[A prospective auto-controlled study to evaluate the interest of selected sperm morphology to inseminate oocytes during IVF]E Grange, G Le Teuff, B Martin-Pont, et al.
Neuroepidemiology|July 11, 2006
The prognostic value of initial relapses on the evolution of disability in patients with relapsing-remitting multiple sclerosisC Binquet, C Quantin, G Le Teuff, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|April 11, 2015
[Individual patient data meta-analyses of randomized trials for the treatment of non-metastatic head and neck squamous cell carcinomas: Principles, results and perspectives]P Blanchard, J Bourhis, B Lacas, et al.
Neuroepidemiology|January 12, 2007
Disability evolution in multiple sclerosis: how to deal with missing transition times in the Markov model?V Petiot, C Quantin, G Le Teuff, et al.
European Journal of Epidemiology|December 7, 2005
A population-based assessment of the prognostic value of the CD19 positive lymphocyte count in B-cell chronic lymphocytic leukemia using Cox and Markov modelsR Cailliod, C Quantin, P M Carli, et al.
Pharmacoepidemiology and Drug Safety|July 2, 2005
Measuring the contribution of pharmacological treatment to advice to stay active in patients with subacute low-back pain: a randomised controlled trialM Rossignol, F A Allaert, S Rozenberg, et al.
Pageof 2